AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 62 filers reported holding AQUESTIVE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.16 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $0 | -100.0% | 21 | -98.5% | 0.00% | – |
| Q2 2021 | $6,000 | -91.8% | 1,398 | -90.1% | 0.00% | – |
| Q1 2021 | $73,000 | -27.7% | 14,132 | -25.3% | 0.00% | – |
| Q4 2020 | $101,000 | -81.1% | 18,917 | -82.8% | 0.00% | – |
| Q3 2020 | $535,000 | +970.0% | 110,277 | +963.5% | 0.00% | – |
| Q2 2020 | $50,000 | +233.3% | 10,369 | +162.0% | 0.00% | – |
| Q2 2019 | $15,000 | -82.1% | 3,957 | -68.1% | 0.00% | – |
| Q1 2019 | $84,000 | +211.1% | 12,391 | +176.8% | 0.00% | – |
| Q4 2018 | $27,000 | -93.1% | 4,477 | -79.9% | 0.00% | – |
| Q3 2018 | $389,000 | – | 22,326 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 9,810,958 | $16,188,081 | 100.00% |
| Vahanian & Associates Financial Planning Inc. | 725,208 | $1,196,593 | 3.78% |
| Bracebridge Capital, LLC | 428,571 | $707,142 | 0.39% |
| Latash Investments, LLC | 243,134 | $401,171 | 0.32% |
| XTX Topco Ltd | 138,145 | $227,939 | 0.04% |
| ARMISTICE CAPITAL, LLC | 1,158,000 | $1,910,700 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 84,355 | $139,186 | 0.01% |
| Hillsdale Investment Management Inc. | 66,600 | $109,890 | 0.01% |
| D.B. Root & Company, LLC | 12,950 | $21,368 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 147,856 | $243,962 | 0.01% |